Kewaunee Scientific Corporation (KEQU)
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Investigation
03/01/2022
Initial Lawsuit
03/16/2022
Lawsuit Progression
06/06/2022
Did Celcius Holdings, Inc. mislead investors regarding its internal controls over financial reporting?
This post is open for investors to gather facts, and findings and track their exposure to related lawsuits. We invite investors and shareholders to contribute to this investigation for their own benefit, add events to the factual timeline below and vote on events’ pertinence.
A lawsuit was subsequently filed. We will update this post as it unfolds.
03/01/2022
Celsius discloses its Q4 and fiscal year 2021 financial results, along with a material weakness in its internal controls over financial reporting related to the misapplication of U.S. GAAP. The company determined that the calculation of expense of non-cash share based compensation related to grants of stock options and restricted stock units “issued to former employees and retired directors was materially understated“. Celsius added that the compensations “were modified and the expense should have been calculated and recognized using the fair market value of the awards as of the date of modification and recognized over the remaining service period.”
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$64.82 | $62.8 | $2.02 | 3.22% |
A Celsius Holdings, Inc. shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Celsius securities between August 12, 2021 and March 1, 2022, inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors:
(1) that the company had improperly recorded expenses for non-cash share-based compensation for second and third quarters of 2021;
(2) that, as a result, the company’s financial statements for those periods would be restated, including to report a net loss for the third quarter of 2021;
(3) that there was a material weakness in Celsius’s internal controls over financial reporting; and
(4) that, as a result of the foregoing, defendants’ positive statements about the company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
06/06/2022
The court issued an order appointing the lead plaintiff and lead counsel.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.